請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45066
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江伯倫(Bor-Luen Chiang) | |
dc.contributor.author | Li-Chieh Wang | en |
dc.contributor.author | 王麗潔 | zh_TW |
dc.date.accessioned | 2021-06-15T04:03:11Z | - |
dc.date.available | 2013-03-12 | |
dc.date.copyright | 2010-03-12 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-02-11 | |
dc.identifier.citation | Abdel-Latif, M. M., H. J. Windle, B. S. Homasany, K. Sabra and D. Kelleher (2005). 'Caffeic acid phenethyl ester modulates Helicobacter pylori-induced nuclear factor-kappa B and activator protein-1 expression in gastric epithelial cells.' Br J Pharmacol 146: 1139-47.
Ahn, M. R., S. Kumazawa, T. Hamasaka, K. S. Bang and T. Nakayama (2004). 'Antioxidant activity and constituents of propolis collected in various areas of Korea.' J Agric Food Chem 52: 7286-92. Ansorge, S., D. Reinhold and U. Lendeckel (2003). 'Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells.' Z Naturforsch [C] 58: 580-9. Anto, J. M., J. B. Soriano, J. Sunyer, M. J. Rodrigo, F. Morell, J. Roca, R. Rodriguez-Roisin and M. C. Swanson (1999). 'Long term outcome of soybean epidemic asthma after an allergen reduction intervention.' Thorax 54: 670-4. Baeuerle, P. A. and T. Henkel (1994). 'Function and activation of NF-kappa B in the immune system.' Annu Rev Immunol 12: 141-79. Bagnasco, M., G. Mariani, G. Passalacqua, C. Motta, M. Bartolomei, P. Falagiani, G. Mistrello and G. W. Canonica (1997). 'Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings.' J Allergy Clin Immunol 100: 122-9. Bahceciler, N. N., U. Isik, I. B. Barlan and M. M. Basaran (2001). 'Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.' Pediatr Pulmonol 32: 49-55. Banchereau, J. and R. M. Steinman (1998). 'Dendritic cells and the control of immunity.' Nature 392: 245-52. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran and K. Palucka (2000). 'Immunobiology of dendritic cells.' Annu Rev Immunol 18: 767-811. Barnes, N. C. and C. J. Miller (2000). 'Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials.' Thorax 55: 478-83. Barnes, P. J., K. F. Chung and C. P. Page (1998). 'Inflammatory mediators of asthma: an update.' Pharmacol Rev 50: 515-96. Barnes, P. J. (2002). 'Cytokine modulators as novel therapies for asthma.' Annu Rev Pharmacol Toxicol 42: 81-98. Barnes, P. J. (2003). 'Theophylline: new perspectives for an old drug.' Am J Respir Crit Care Med 167: 813-8. Bateman, E. D., H. A. Boushey, J. Bousquet, W. W. Busse, T. J. Clark, R. A. Pauwels and S. E. Pedersen (2004). 'Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.' Am J Respir Crit Care Med 170: 836-44. Beals, C. R., C. M. Sheridan, C. W. Turck, P. Gardner and G. R. Crabtree (1997). 'Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3.' Science 275: 1930-4. Bellinghausen, I., U. Brand, J. Knop and J. Saloga (2000). 'Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors.' J Allergy Clin Immunol 105: 988-96. Beuther, D. A., S. T. Weiss and E. R. Sutherland (2006). 'Obesity and asthma.' Am J Respir Crit Care Med 174: 112-9. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens and T. P. Salazar-Mather (1999). 'Natural killer cells in antiviral defense: function and regulation by innate cytokines.' Annu Rev Immunol 17: 189-220. Bochner, B. S. and W. W. Busse (2005). 'Allergy and asthma.' J Allergy Clin Immunol 115: 953-9. Bonizzi, G. and M. Karin (2004). 'The two NF-kappaB activation pathways and their role in innate and adaptive immunity.' Trends Immunol 25: 280-8. Brennan, P., J. W. Babbage, B. M. Burgering, B. Groner, K. Reif and D. A. Cantrell (1997). 'Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.' Immunity 7: 679-89. Brennan, P., J. W. Babbage, G. Thomas and D. Cantrell (1999). 'p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes.' Mol Cell Biol 19: 4729-38. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman and S. I. Wasserman (1992). 'Cytokines in symptomatic asthma airways.' J Allergy Clin Immunol 89: 958-67. Bumbacea, D., D. Campbell, L. Nguyen, D. Carr, P. J. Barnes, D. Robinson and K. F. Chung (2004). 'Parameters associated with persistent airflow obstruction in chronic severe asthma.' Eur Respir J 24: 122-8. Burgering, B. M. and G. J. Kops (2002). 'Cell cycle and death control: long live Forkheads.' Trends Biochem Sci 27: 352-60. Byrne P, B. E., Bousquet J, Clark T, Ohta K, Paggiaro P, Pedersen SE, Singh RB, Tan WC (2007). Global strategy for asthma management and prevention, Medical Communications Resources, Inc. Calhoun, W. J. (2003). 'Nocturnal asthma.' Chest 123: 399S-405S. Canonica, G. W. and G. Passalacqua (2003). 'Noninjection routes for immunotherapy.' J Allergy Clin Immunol 111: 437-48; quiz 449. Cantrell, D. (2002). 'Protein kinase B (Akt) regulation and function in T lymphocytes.' Semin Immunol 14: 19-26. Carlsen, K. H. (2005). 'Pharmaceutical treatment of asthma in children.' Curr Drug Targets Inflamm Allergy 4: 543-9. Chalmers, G. W., K. J. Macleod, S. A. Little, L. J. Thomson, C. P. McSharry and N. C. Thomson (2002). 'Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma.' Thorax 57: 226-30. Chan-Yeung, M. and J. L. Malo (1994). 'Aetiological agents in occupational asthma.' Eur Respir J 7: 346-71. Chan, C. B. and K. Ye (2007). 'PIKE GTPase are phosphoinositide-3-kinase enhancers, suppressing programmed cell death.' J Cell Mol Med 11: 39-53. Chaudhuri, R., E. Livingston, A. D. McMahon, L. Thomson, W. Borland and N. C. Thomson (2003). 'Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma.' Am J Respir Crit Care Med 168: 1308-11. Chen, L. L., I. B. Tager, D. B. Peden, D. L. Christian, R. E. Ferrando, B. S. Welch and J. R. Balmes (2004). 'Effect of ozone exposure on airway responses to inhaled allergen in asthmatic subjects.' Chest 125: 2328-35. Chen, M. L., F. H. Wang, P. K. Lee and C. M. Lin (2001). 'Interleukin-10-induced T cell unresponsiveness can be reversed by dendritic cell stimulation.' Immunol Lett 75: 91-6. Chen, Y. J., M. S. Shiao, M. L. Hsu, T. H. Tsai and S. Y. Wang (2001). 'Effect of caffeic acid phenethyl ester, an antioxidant from propolis, on inducing apoptosis in human leukemic HL-60 cells.' J Agric Food Chem 49: 5615-9. Chiao, C., A. M. Carothers, D. Grunberger, G. Solomon, G. A. Preston and J. C. Barrett (1995). 'Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells.' Cancer Res 55: 3576-83. Choi, K. and C. Choi (2008). 'Differential regulation of c-Jun N-terminal kinase and NF-kappaB pathway by caffeic acid phenethyl ester in astroglial and monocytic cells.' J Neurochem 105: 557-64. Ciprandi, G., D. Fenoglio, I. Cirillo, A. Vizzaccaro, A. Ferrera, M. A. Tosca and F. Puppo (2005). 'Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report.' Ann Allergy Asthma Immunol 95: 38-44. Cohen, G. M. (1997). 'Caspases: the executioners of apoptosis.' Biochem J 326 ( Pt 1): 1-16. Cohen, H. A., I. Varsano, E. Kahan, E. M. Sarrell and Y. Uziel (2004). 'Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study.' Arch Pediatr Adolesc Med 158: 217-21. Cohn, L., J. A. Elias and G. L. Chupp (2004). 'Asthma: mechanisms of disease persistence and progression.' Annu Rev Immunol 22: 789-815. Committee, A. A. o. P. C. o. E. H. (1997). 'Environmental tobacco smoke: a hazard to children. American Academy of Pediatrics Committee on Environmental Health Committee.' Pediatrics 99: 639-42. Corinti, S., C. Albanesi, A. la Sala, S. Pastore and G. Girolomoni (2001). 'Regulatory activity of autocrine IL-10 on dendritic cell functions.' J Immunol 166: 4312-8. Crabtree, G. R. and N. A. Clipstone (1994). 'Signal transmission between the plasma membrane and nucleus of T lymphocytes.' Annu Rev Biochem 63: 1045-83. Crabtree, G. R. (2001). 'Calcium, calcineurin, and the control of transcription.' J Biol Chem 276: 2313-6. Custovic, A., S. C. Taggart, H. C. Francis, M. D. Chapman and A. Woodcock (1996). 'Exposure to house dust mite allergens and the clinical activity of asthma.' J Allergy Clin Immunol 98: 64-72. Davies, B., G. Brooks and M. Devoy (1998). 'The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies.' Respir Med 92: 256-63. De Wit, D., Z. Amraoui, B. Vincart, O. Michel, A. Michils, L. Van Overvelt, F. Willems and M. Goldman (2000). 'Helper T-cell responses elicited by Der p 1-pulsed dendritic cells and recombinant IL-12 in atopic and healthy subjects.' J Allergy Clin Immunol 105: 346-52. Devereux, G. and A. Seaton (2005). 'Diet as a risk factor for atopy and asthma.' J Allergy Clin Immunol 115: 1109-17; quiz 1118. DeWire, S. M., S. Ahn, R. J. Lefkowitz and S. K. Shenoy (2007). 'Beta-arrestins and cell signaling.' Annu Rev Physiol 69: 483-510. Di Rienzo, V., F. Marcucci, P. Puccinelli, S. Parmiani, F. Frati, L. Sensi, G. W. Canonica and G. Passalacqua (2003). 'Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.' Clin Exp Allergy 33: 206-10. Dicpinigaitis, P. V., J. B. Dobkin and J. Reichel (2002). 'Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma.' J Asthma 39: 291-7. Dodeller, F. and H. Schulze-Koops (2006). 'The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells.' Arthritis Res Ther 8: 205. Drazen, J. M., E. Israel and P. M. O'Byrne (1999). 'Treatment of asthma with drugs modifying the leukotriene pathway.' N Engl J Med 340: 197-206. Duez, C., P. Gosset and A. B. Tonnel (2006). 'Dendritic cells and toll-like receptors in allergy and asthma.' Eur J Dermatol 16: 12-6. Eisenbarth, S. C., D. A. Piggott and K. Bottomly (2003). 'The master regulators of allergic inflammation: dendritic cells in Th2 sensitization.' Curr Opin Immunol 15: 620-6. Epstein, M. M. (2006). 'Targeting memory Th2 cells for the treatment of allergic asthma.' Pharmacol Ther 109: 107-36. Fish, J. E. and S. P. Peters (1999). 'Airway remodeling and persistent airway obstruction in asthma.' J Allergy Clin Immunol 104: 509-16. Foti, M., F. Granucci and P. Ricciardi-Castagnoli (2006). 'Dendritic cell interactions and cytokine production.' Ernst Schering Res Found Workshop: 61-80. Frew, A. J., P. J. White and H. E. Smith (1999). 'Sublingual immunotherapy.' J Allergy Clin Immunol 104: 267-70. Frew, A. J. and H. E. Smith (2001). 'Sublingual immunotherapy.' J Allergy Clin Immunol 107: 441-4. Friedman, N. J. and R. S. Zeiger (2005). 'The role of breast-feeding in the development of allergies and asthma.' J Allergy Clin Immunol 115: 1238-48. Fu, C. L., Y. H. Chuang, H. Y. Huang and B. L. Chiang (2008). 'Induction of IL-10 producing CD4+ T cells with regulatory activities by stimulation with IL-10 gene-modified bone marrow derived dendritic cells.' Clin Exp Immunol 153: 258-68. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams and M. Tsai (2005). 'Mast cells as 'tunable' effector and immunoregulatory cells: recent advances.' Annu Rev Immunol 23: 749-86. Galon, J., C. Sudarshan, S. Ito, D. Finbloom and J. J. O'Shea (1999). 'IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells.' J Immunol 162: 7256-62. Gauvreau, G. M., E. M. Hessel, L. P. Boulet, R. L. Coffman and P. M. O'Byrne (2006). 'Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses.' Am J Respir Crit Care Med 174: 15-20. Gerke, V. and S. E. Moss (2002). 'Annexins: from structure to function.' Physiol Rev 82: 331-71. Gern, J. E. and W. W. Busse (2002). 'Relationship of viral infections to wheezing illnesses and asthma.' Nat Rev Immunol 2: 132-8. Ghaemmaghami, A. M., A. Robins, L. Gough, H. F. Sewell and F. Shakib (2001). 'Human T cell subset commitment determined by the intrinsic property of antigen: the proteolytic activity of the major mite allergen Der p 1 conditions T cells to produce more IL-4 and less IFN-gamma.' Eur J Immunol 31: 1211-6. Ghosh, S., M. J. May and E. B. Kopp (1998). 'NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.' Annu Rev Immunol 16: 225-60. Gleich, G. J., N. A. Flavahan, T. Fujisawa and P. M. Vanhoutte (1988). 'The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity.' J Allergy Clin Immunol 81: 776-81. Glimcher, L. H. and K. M. Murphy (2000). 'Lineage commitment in the immune system: the T helper lymphocyte grows up.' Genes Dev 14: 1693-711. Gloire, G., S. Legrand-Poels and J. Piette (2006). 'NF-kappaB activation by reactive oxygen species: fifteen years later.' Biochem Pharmacol 72: 1493-505. Group, T. C. A. M. P. R. G. (2000). 'Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group.' N Engl J Med 343: 1054-63. Ha, J., H. S. Choi, Y. Lee, Z. H. Lee and H. H. Kim (2009). 'Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos.' Int Immunopharmacol 9: 774-80. Haahtela, T., M. Jarvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, O. Selroos, A. Sovijarvi and et al. (1994). 'Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.' N Engl J Med 331: 700-5. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin and E. W. Gelfand (1997). 'Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography.' Am J Respir Crit Care Med 156: 766-75. Hammad, H., A. S. Charbonnier, C. Duez, A. Jacquet, G. A. Stewart, A. B. Tonnel and J. Pestel (2001). 'Th2 polarization by Der p 1--pulsed monocyte-derived dendritic cells is due to the allergic status of the donors.' Blood 98: 1135-41. Hammad, H. and B. N. Lambrecht (2006). 'Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation.' J Allergy Clin Immunol 118: 331-6. Harris, N. L., V. Watt, F. Ronchese and G. Le Gros (2002). 'Differential T cell function and fate in lymph node and nonlymphoid tissues.' J Exp Med 195: 317-26. Hart, L. A., V. L. Krishnan, I. M. Adcock, P. J. Barnes and K. F. Chung (1998). 'Activation and localization of transcription factor, nuclear factor-kappaB, in asthma.' Am J Respir Crit Care Med 158: 1585-92. Henderson, W. R., Jr., L. O. Tang, S. J. Chu, S. M. Tsao, G. K. Chiang, F. Jones, M. Jonas, C. Pae, H. Wang and E. Y. Chi (2002). 'A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.' Am J Respir Crit Care Med 165: 108-16. Hendrzak, J. A. and M. J. Brunda (1995). 'Interleukin-12. Biologic activity, therapeutic utility, and role in disease.' Lab Invest 72: 619-37. Hewitt, C. R., A. P. Brown, B. J. Hart and D. I. Pritchard (1995). 'A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases.' J Exp Med 182: 1537-44. Hirst, S. J., J. G. Martin, J. V. Bonacci, V. Chan, E. D. Fixman, Q. A. Hamid, B. Herszberg, J. P. Lavoie, C. G. McVicker, L. M. Moir, T. T. Nguyen, Q. Peng, D. Ramos-Barbon and A. G. Stewart (2004). 'Proliferative aspects of airway smooth muscle.' J Allergy Clin Immunol 114: S2-17. Hogaboam, C. M., K. J. Carpenter, J. M. Schuh and K. F. Buckland (2005). 'Aspergillus and asthma--any link?' Med Mycol 43 Suppl 1: S197-202. Holgate, S. T., P. M. Lackie, D. E. Davies, W. R. Roche and A. F. Walls (1999). 'The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma.' Clin Exp Allergy 29 Suppl 2: 90-5. Holgate, S. T., M. Peters-Golden, R. A. Panettieri and W. R. Henderson, Jr. (2003). 'Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.' J Allergy Clin Immunol 111: S18-34; discussion S34-6. Holloway, J. W., B. Beghe and S. T. Holgate (1999). 'The genetic basis of atopic asthma.' Clin Exp Allergy 29: 1023-32. Holt, P. G., M. A. Schon-Hegrad, J. Oliver, B. J. Holt and P. G. McMenamin (1990). 'A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium.' Int Arch Allergy Appl Immunol 91: 155-9. Holt, P. G. (1995). 'Environmental factors and primary T-cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution.' Pediatr Allergy Immunol 6: 1-10. Horwood, L. J., D. M. Fergusson and F. T. Shannon (1985). 'Social and familial factors in the development of early childhood asthma.' Pediatrics 75: 859-68. Hsieh, C. S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra and K. M. Murphy (1993). 'Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.' Science 260: 547-9. Huang, M. T., W. Ma, P. Yen, J. G. Xie, J. Han, K. Frenkel, D. Grunberger and A. H. Conney (1996). 'Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells.' Carcinogenesis 17: 761-5. Huh, J. C., D. H. Strickland, F. L. Jahnsen, D. J. Turner, J. A. Thomas, S. Napoli, I. Tobagus, P. A. Stumbles, P. D. Sly and P. G. Holt (2003). 'Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma.' J Exp Med 198: 19-30. Humbert, M., R. Beasley, J. Ayres, R. Slavin, J. Hebert, J. Bousquet, K. M. Beeh, S. Ramos, G. W. Canonica, S. Hedgecock, H. Fox, M. Blogg and K. Surrey (2005). 'Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.' Allergy 60: 309-16. Humbles, A. A., C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, E. E. McKenna, S. Ghiran, N. P. Gerard, C. Yu, S. H. Orkin and C. Gerard (2004). 'A critical role for eosinophils in allergic airways remodeling.' Science 305: 1776-9. Hung, C. H., Y. T. Chu, Y. M. Hua, S. H. Hsu, C. S. Lin, H. C. Chang, M. S. Lee and Y. J. Jong (2008). 'Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells.' Eur Respir J 31: 1313-21. Iellem, A., M. Mariani, R. Lang, H. Recalde, P. Panina-Bordignon, F. Sinigaglia and D. D'Ambrosio (2001). 'Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.' J Exp Med 194: 847-53. In, K. H., K. Asano, D. Beier, J. Grobholz, P. W. Finn, E. K. Silverman, E. S. Silverman, T. Collins, A. R. Fischer, T. P. Keith, K. Serino, S. W. Kim, G. T. De Sanctis, C. Yandava, A. Pillari, P. Rubin, J. Kemp, E. Israel, W. Busse, D. Ledford, J. J. Murray, A. Segal, D. Tinkleman and J. M. Drazen (1997). 'Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.' J Clin Invest 99: 1130-7. Inaba, K. and R. M. Steinman (1984). 'Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release.' J Exp Med 160: 1717-35. Ingulli, E., A. Mondino, A. Khoruts and M. K. Jenkins (1997). 'In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.' J Exp Med 185: 2133-41. Ito, K., K. F. Chung and I. M. Adcock (2006). 'Update on glucocorticoid action and resistance.' J Allergy Clin Immunol 117: 522-43. Jayakumar, A., M. J. Donovan, V. Tripathi, M. Ramalho-Ortigao and M. A. McDowell (2008). 'Leishmania major infection activates NF-kappaB and interferon regulatory factors 1 and 8 in human dendritic cells.' Infect Immun 76: 2138-48. Jeffery, P. K., R. W. Godfrey, E. Adelroth, F. Nelson, A. Rogers and S. A. Johansson (1992). 'Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study.' Am Rev Respir Dis 145: 890-9. Jin, U. H., K. H. Song, M. Motomura, I. Suzuki, Y. H. Gu, Y. J. Kang, T. C. Moon and C. H. Kim (2008). 'Caffeic acid phenethyl ester induces mitochondria-mediated apoptosis in human myeloid leukemia U937 cells.' Mol Cell Biochem 310: 43-8. Jung, W. K., D. Y. Lee, Y. H. Choi, S. S. Yea, I. Choi, S. G. Park, S. K. Seo, S. W. Lee, C. M. Lee, S. K. Kim, Y. J. Jeon and I. W. Choi (2008). 'Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma.' Life Sci 82: 797-805. Juniper, E. F., P. A. Kline, M. A. Vanzieleghem, E. H. Ramsdale, P. M. O'Byrne and F. E. Hargreave (1990). 'Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics.' Am Rev Respir Dis 142: 832-6. Jutel, M., M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, K. Blaser and C. A. Akdis (2003). 'IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy.' Eur J Immunol 33: 1205-14. Kallinich, T., S. Schmidt, E. Hamelmann, A. Fischer, S. Qin, W. Luttmann, J. C. Virchow and R. A. Kroczek (2005). 'Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients.' Clin Exp Allergy 35: 26-33. Kallinich, T., K. C. Beier, U. Wahn, P. Stock and E. Hamelmann (2007). 'T-cell co-stimulatory molecules: their role in allergic immune reactions.' Eur Respir J 29: 1246-55. Kane, L. P. and A. Weiss (2003). 'The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3.' Immunol Rev 192: 7-20. Kay, A. B. (1991). 'T lymphocytes and their products in atopic allergy and asthma.' Int Arch Allergy Appl Immunol 94: 189-93. Kay, A. B., S. Phipps and D. S. Robinson (2004). 'A role for eosinophils in airway remodelling in asthma.' Trends Immunol 25: 477-82. Kay, A. B. (2006). 'The role of T lymphocytes in asthma.' Chem Immunol Allergy 91: 59-75. Khayyal, M. T., M. A. el-Ghazaly, A. S. el-Khatib, A. M. Hatem, P. J. de Vries, S. el-Shafei and M. M. Khattab (2003). 'A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients.' Fundam Clin Pharmacol 17: 93-102. Kidney, J., M. Dominguez, P. M. Taylor, M. Rose, K. F. Chung and P. J. Barnes (1995). 'Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy.' Am J Respir Crit Care Med 151: 1907-14. Kleijmeer, M., G. Ramm, D. Schuurhuis, J. Griffith, M. Rescigno, P. Ricciardi-Castagnoli, A. Y. Rudensky, F. Ossendorp, C. J. Melief, W. Stoorvogel and H. J. Geuze (2001). 'Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells.' J Cell Biol 155: 53-63. Kollet, J., C. Witek, J. D. Gentry, X. Liu, S. D. Schwartzbach and T. M. Petro (2001). 'Deletional analysis of the murine IL-12 p35 promoter comparing IFN-gamma and lipopolysaccharide stimulation.' J Immunol 167: 5653-63. Komine, O., K. Hayashi, W. Natsume, T. Watanabe, Y. Seki, N. Seki, R. Yagi, W. Sukzuki, H. Tamauchi, K. Hozumi, S. Habu, M. Kubo and M. Satake (2003). 'The Runx1 transcription factor inhibits the differentiation of naive CD4+ T cells into the Th2 lineage by repressing GATA3 expression.' J Exp Med 198: 51-61. Kopp, E. B. and S. Ghosh (1995). 'NF-kappa B and rel proteins in innate immunity.' Adv Immunol 58: 1-27. Kuipers, H. and B. N. Lambrecht (2004). 'The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma.' Curr Opin Immunol 16: 702-8. Kuperman, D. A., X. Huang, L. L. Koth, G. H. Chang, G. M. Dolganov, Z. Zhu, J. A. Elias, D. Sheppard and D. J. Erle (2002). 'Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma.' Nat Med 8: 885-9. Lafont, V., E. Astoul, A. Laurence, J. Liautard and D. Cantrell (2000). 'The T cell antigen receptor activates phosphatidylinositol 3-kinase-regulated serine kinases protein kinase B and ribosomal S6 kinase 1.' FEBS Lett 486: 38-42. Laitinen, L. A., A. Laitinen, T. Haahtela, V. Vilkka, B. W. Spur and T. H. Lee (1993). 'Leukotriene E4 and granulocytic infiltration into asthmatic airways.' Lancet 341: 989-90. Lambrecht, B. N. and L. S. van Rijt (2006). 'Infections and asthma pathogenesis: a critical role for dendritic cells?' Novartis Found Symp 279: 187-200; discussion 200-5, 216-9. Lane, S. J., A. R. Sousa and T. H. Lee (1994). 'The role of the macrophage in asthma.' Allergy 49: 201-9. Larche, M., D. S. Robinson and A. B. Kay (2003). 'The role of T lymphocytes in the pathogenesis of asthma.' J Allergy Clin Immunol 111: 450-63; quiz 464. Larche, M., D. S. Robinson and A. B. Kay (2003). 'The role of T lymphocytes in the pathogenesis of asthma.' J Allergy Clin Immunol 111: 450-63. Larche, M. (2006). 'Immunoregulation by targeting T cells in the treatment of allergy and asthma.' Curr Opin Immunol 18: 745-50. Lauder, A., A. Castellanos and K. Weston (2001). 'c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of Tcells and is required for PKB-mediated protection from apoptosis.' Mol Cell Biol 21: 5797-805. Lazarus, S. C., H. A. Boushey, J. V. Fahy, V. M. Chinchilli, R. F. Lemanske, Jr., C. A. Sorkness, M. Kraft, J. E. Fish, S. P. Peters, T. Craig, J. M. Drazen, J. G. Ford, E. Israel, R. J. Martin, E. A. Mauger, S. A. Nachman, J. D. Spahn and S. J. Szefler (2001). 'Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.' JAMA 285: 2583-93. Lee, E. S., J. O. Lee, S. K. Lee, J. H. Kim, J. H. Jung, B. Keum, S. H. Park and H. S. Kim (2009). 'Caffeic acid phenethyl ester accumulates beta-catenin through GSK-3beta and participates in proliferation through mTOR in C2C12 cells.' Life Sci 84: 755-9. Lee, J. J., D. Dimina, M. P. Macias, S. I. Ochkur, M. P. McGarry, K. R. O'Neill, C. Protheroe, R. Pero, T. Nguyen, S. A. Cormier, E. Lenkiewicz, D. Colbert, L. Rinaldi, S. J. Ackerman, C. G. Irvin and N. A. Lee (2004). 'Defining a link with asthma in mice congenitally deficient in eosinophils.' Science 305: 1773-6. Lee, Y. J., H. C. Kuo, C. Y. Chu, C. J. Wang, W. C. Lin and T. H. Tseng (2003). 'Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells.' Biochem Pharmacol 66: 2281-9. Lee, Y. L., C. L. Fu, Y. L. Ye and B. L. Chiang (1999). 'Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation.' Scand J Immunol 49: 229-36. Leff, A. R. (2001). 'Regulation of leukotrienes in the management of asthma: biology and clinical therapy.' Annu Rev Med 52: 1-14. Leigh, R., R. Ellis, J. N. Wattie, J. A. Hirota, K. I. Matthaei, P. S. Foster, P. M. O'Byrne and M. D. Inman (2004). 'Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice.' Am J Respir Crit Care Med 169: 860-7. Lemanske, R. F., Jr., C. A. Sorkness, E. A. Mauger, S. C. Lazarus, H. A. Boushey, J. V. Fahy, J. M. Drazen, V. M. Chinchilli, T. Craig, J. E. Fish, J. G. Ford, E. Israel, M. Kraft, R. J. Martin, S. A. Nachman, S. P. Peters, J. D. Spahn and S. J. Szefler (2001). 'Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial.' JAMA 285: 2594-603. Levy, M. L., M. Fletcher, D. B. Price, T. Hausen, R. J. Halbert and B. P. Yawn (2006). 'International Primary Care Respiratory Group (IPCRG) Guidelines: diagnosis of respiratory diseases in primary care.' Prim Care Respir J 15: 20-34. Lin, Y. L., Y. C. Liang, S. S. Lee and B. L. Chiang (2005). 'Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways.' J Leukoc Biol 78: 533-43. Lindner, I., P. J. Cejas, L. M. Carlson, J. Torruellas, G. V. Plano and K. P. Lee (2007). 'Signal transduction in DC differentiation: winged messengers and Achilles' heel.' Adv Exp Med Biol 590: 1-29. Lipworth, B. J. (1999). 'Leukotriene-receptor antagonists.' Lancet 353: 57-62. Liu, J., S. Cao, L. M. Herman and X. Ma (2003). 'Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1.' J Exp Med 198: 1265-76. Liu, L., B. E. Rich, J. Inobe, W. Chen and H. L. Weiner (1998). 'Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4.' Int Immunol 10: 1017-26. Lommatzsch, M., P. Julius, M. Kuepper, H. Garn, K. Bratke, S. Irmscher, W. Luttmann, H. Renz, A. Braun and J. C. Virchow (2006). 'The course of allergen-induced leukocyte infiltration in human and experimental asthma.' J Allergy Clin Immunol 118: 91-7. Lundgren, J. D. and J. H. Shelhamer (1990). 'Pathogenesis of airway mucus hypersecretion.' J Allergy Clin Immunol 85: 399-417. Luster, A. D., J. C. Unkeless and J. V. Ravetch (1985). 'Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.' Nature 315: 672-6. Macatonia, S. E., N. A. Hosken, M. Litton, P. Vieira, C. S. Hsieh, J. A. Culpepper, M. Wysocka, G. Trinchieri, K. M. Murphy and A. O'Garra (1995). 'Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.' J Immunol 154: 5071-9. Malo, J. L., C. Lemiere, D. Gautrin and M. Labrecque (2004). 'Occupational asthma.' Curr Opin Pulm Med 10: 57-61. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi and M. Locati (2004). 'The chemokine system in diverse forms of macrophage activation and polarization.' Trends Immunol 25: 677-86. Marathias, K. P., F. I. Preffer, C. Pinto and R. L. Kradin (1991). 'Most human pulmonary infiltrating lymphocytes display the surface immune phenotype and functional responses of sensitized T cells.' Am J Respir Cell Mol Biol 5: 470-6. Marks, G. B., J. R. Colquhoun, S. T. Girgis, M. H. Koski, A. B. Treloar, P. Hansen, S. H. Downs and N. G. Car (2001). 'Thunderstorm outflows preceding epidemics of asthma during spring and summer.' Thorax 56: 468-71. Marquez, N., R. Sancho, A. Macho, M. A. Calzado, B. L. Fiebich and E. Munoz (2004). 'Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.' J Pharmacol Exp Ther 308: 993-1001. Masoli, M., D. Fabian, S. Holt and R. Beasley (2004). 'The global burden of asthma: executive summary of the GINA Dissemination Committee report.' Allergy 59: 469-78. Mayatepek, E. and G. F. Hoffmann (1995). 'Leukotrienes: biosynthesis, metabolism, and pathophysiologic significance.' Pediatr Res 37: | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45066 | - |
dc.description.abstract | 氣喘是兒童主要的慢性病,近年來治療的進步,如吸入性類固醇 (目前的主要治療)、茶鹼、長效型beta2-adrenergic agonist、白三烯素拮抗劑和抗IgE抗體等已大幅減少了氣喘的死亡率和併發症,但仍無法完全控制困難治療的氣喘病患,因此我們想探討其他的治療方法及其機轉。 蜂膠是一種古老的傳統草藥,將蜂膠萃取物用於輕度至中度的氣喘病人作為輔助治療已被報告可以改善夜間症狀及肺功能。 雖然蜂膠的成分因不同地區的植物不同而有差異,其中的一種獨特成分-咖啡酸苯乙酯 [ caffeic acid phenethyl ester (CAPE) ] 廣泛存在於大部分的蜂膠中,且被報告有抗腫瘤、抗發炎、抗氧化及抗病毒的作用。 由於樹突細胞及Th2細胞在氣喘的致病機轉中扮演著重要的角色,因此本研究以咖啡酸苯乙酯與來自健康人及過敏病人被刺激活化的樹突細胞及T細胞共同培養,以探討咖啡酸苯乙酯對於健康人及過敏病人的樹突細胞及T細胞的免疫功能之影響。
首先,我們抽取人類週邊血分離出單核細胞中的CD14+ 單核球,再以GM-CSF及IL-4培養出樹突細胞 (monocyte-derived dendritic cells),以此體外培養系統來研究咖啡酸苯乙酯對於樹突細胞的影響。 我們以咖啡酸苯乙酯與塵蟎萃取物或LPS共同刺激樹突細胞,以ELISA的方式檢測樹突細胞分泌的數種激素; 我們發現咖啡酸苯乙酯可以抑制來自於健康人被LPS刺激的樹突細胞所分泌的 IL-12 p40、IL-12 p70及IL-10,及被塵蟎萃取物刺激所分泌的IL-12 p40、IL-10 及IP-10; 在塵蟎過敏的病人中,咖啡酸苯乙酯可以抑制被塵蟎萃取物刺激的樹突細胞所分泌的IL-10 及IP-10。 接著我們以流式細胞儀分析樹突細胞的表面分子及其吞噬dextran-FITC的量以了解樹突細胞的成熟狀態; 我們發現咖啡酸苯乙脂並不影響MHC分子及costimulatory分子在細胞表面的表現以及樹突細胞的吞噬能力。 我們將刺激處理過的樹突細胞與自體naïve CD4+ T細胞共同培養,結果T細胞產生的細胞激素及複製增生並不受影響,換言之,咖啡酸苯乙酯並不影響樹突細胞呈現抗原給T細胞的抗原呈現能力。 為了進一步了解咖啡酸苯乙酯抑制細胞激素的機轉,我們使用LPS刺激樹突細胞並萃取其細胞蛋白質以西方點墨法來測定其訊息傳導路徑的改變; 我們發現咖啡酸苯乙酯會抑制被LPS刺激的樹突細胞所產生的I kappa B alpha磷酸化及NF-kappa B活化,但不影響MAPK家族的磷酸化。 因此,咖啡酸苯乙酯可以藉由抑制NF-kappa B的訊息傳導路徑來抑制樹突細胞分泌細胞激素的能力,且對於Th2細胞激素 (IL-10) 的抑制比率比Th1細胞激素 (IL-12) 的抑制比率高。 接著,我們抽取人類週邊血分離出單核細胞中的CD4+ T細胞,以研究咖啡酸苯乙酯對於T細胞直接的影響。 首先,我們使用soluble anti-CD3及anti-CD28單株抗體來刺激素T細胞以EILSA測定其所分泌的細胞激素,並使用tritiated thymidine incorporation的方式來測定T細胞的複製增生; 我們發現咖啡酸苯乙酯可以抑制來自於健康人及過敏病人被刺激的T細胞所分泌的IFN-gamma及IL-5,以及淋巴球的複製增生。 接著我們以西方點墨法來測定其息傳導路徑以了解咖啡酸苯乙酯的抑制機轉; 結果咖啡酸苯乙酯會抑制被soluble anti-CD3及anti-CD28單株抗體刺激的T細胞所產生的IKK及I kappa B alpha磷酸化、NF-kappa B活化及Akt磷酸化,但不影響p38 MAPK的磷酸化。 此外我們利用流式細胞儀來分析被咖啡酸苯乙酯處理過的T細胞內所表現的早期凋亡因子active caspase-3; 結果咖啡酸苯乙酯會使T細胞表現早期凋亡因子active caspase-3,而且CCR4+CD4+ T 細胞比 CXCR3+CD4+ T細胞更容易表現active caspase-3。 因此,咖啡酸苯乙酯可以藉由抑制NF-kappa B及Akt的訊息傳導路徑來抑制T細胞分泌細胞激素及細胞複製增生,且咖啡酸苯乙酯也會使T細胞表現早期凋亡因子active caspase-3,尤其是CCR4+CD4+ T 細胞,因此使這種似Th2細胞較容易產生細胞凋亡。 經由上述的研究我們發現了咖啡酸苯乙酯可以藉由抑制NF-kappa B及Akt的訊息傳導路徑來抑制樹突細胞及T細胞分泌細胞激素及淋巴球增生,因而抑制了下游的發炎反應; 咖啡酸苯乙酯也會使T細胞表現早期凋亡因子active caspase-3,尤其是CCR4+CD4+ T 細胞,因此使這種似Th2細胞較容易產生細胞凋亡,進而減少氣喘的後期發炎反應。 本研究建立了咖啡酸苯乙酯在治療氣喘及其他過敏疾病的角色,進而提供蜂膠在治療過敏疾病的學理基礎。 | zh_TW |
dc.description.abstract | Asthma is the leading chronic disease in children. The mortality and morbidity of asthma has been decreased recently due to the advance of management of asthma. The treatment of asthma includes inhaled corticosteroid (the main drug), theophylline, long-acting beta2-agnoist, leukotriene antagonist and anti-IgE, etc. However, some severe difficult to treat patients still not achieve controlled under these treatments. We therefore intend to evaluate other potential treatments and their mechanism. Propolis, an ancient herbal medicine, has been reported the beneficial effect both in asthma patients and murine model of asthma, but the mechanism was not clearly understood. Caffeic acid phenethyl ester (CAPE), a unique active component in propolis, is known to have anti-tumor, anti-inflammatory and antioxidant properties. Since Th2 cells and dendritic cells play important roles in the pathogenesis of asthma, we use CAPE to treat CD4+ T cells and monocyte-derived dendritic cells (MoDCs) from healthy subjects and allergic patients to evaluate the effects of CAPE on the functions of human MoDCs and primary human CD4+ T cells in vitro.
First, peripheral blood mononuclear cells (PBMCs) were isolated from non-atopic healthy subjects and mite-sensitized allergic patients. The CD14+ monocytes were isolated by autoMACS and cultured with GM-CSF and IL-4 to become MoDCs. We check the cytokine levels of stimulated MoDCs by ELISA. We found that CAPE significantly inhibited IL-12 p40, IL-12 p70, IL-10 protein expression in mature healthy human MoDCs stimulated by lipopolysaccharides (LPS) and IL-12 p40, IL-10, IP-10 stimulated by crude mite extract. CAPE significantly inhibited IL-10 and IP-10 but not IL-12 expression in allergic patients’ MoDCs stimulated by crude mite extract. Further, we evaluated the surface markers and dextran-FITC by flow cytometry. We found that the upregulation of costimulatory molecules and phagocytosis alibity in mature MoDCs was not altered by CAPE. Therefore, the antigen presenting ability of MoDCs was not inhibited by CAPE by evaluating the cytokine levels and lymphoproliferation of the co-cultured autologous naïve CD4+ T cells. To study the mechanism of the inhibitory effect of CAPE, we extract the protein from LPS-stimulated MoDCs and check the signaling transduction by Western blot. CAPE inhibited I kappa B alpha phosphorylation and nuclear factor (NF)-kappa B activation but not mitogen-activated protein kinase (MAPK) family phosphorylation in human MoDCs. Together, CAPE inhibited the cytokine production of MoDCS by the inhibition of NF-kappa B activation and the inhibition rate of Th2 cytokine (IL-10) was higher than that of Th1 cytokine (IL-12). Next, we isolated CD4+ T cells from PBMCs of healthy subjects and mite-sensitized asthma patients by autoMACS. We check the cytokine production from stimulated T cells by ELISA and the lymphoproliferation by tritiated thymidine incorporation method. CAPE significantly suppressed IFN-gamma and IL-5 production and proliferation of CD4+ T cells stimulated by soluble anti-CD3 and anti-CD28 monoclonal antibodies both in healthy subjects and asthmatic patients. The signaling pathways were evaluated by Western blot. CAPE inhibited NF-kappa B activation and protein kinase B (Akt) phosphorylation, but not p38 MAPK phosphorylation in T cells. Besides, we evaluated the intracellular active caspase-3 expression by flow cytometry. CAPE could induce active caspase-3 expression in CD4+ T cells; CCR4+CD4+ T cells were more sensitive to CAPE induction than CxCR3+CD4+ T cells. Therefore, CAPE inhibited the cytokine production and lymphoproliferation of CD4+ T cells by the inhibition of NF-kappa B and Akt activation. CCR4+CD4+ T cells were more sensitive to CAPE induced active caspase-3 expression than CxCR3+CD4+ T cells, which indicated that Th2-like cells were more vulnerable to apoptosis and the late phase of allergic inflammation may decreased by CAPE treatment. To summary, our study indicated that CAPE inhibited cytokine and chemokine production by MoDCs and cytokine production and proliferation of T cells which might be related to the NF-kappa B and Akt signaling pathways. CCR4+CD4+ T cells are more sensitive to CAPE inhibition, which would result in decreased downstream inflammatory processes. This study provided a new insight into the mechanism of CAPE in immune response and the rationale for propolis in the treatment of asthma and other allergic disorders. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T04:03:11Z (GMT). No. of bitstreams: 1 ntu-99-D92421007-1.pdf: 7134128 bytes, checksum: fd9ec1544367e140ccb52d45a4b52be5 (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 口試委員會審定書 ……………………………………………... i
誌謝 ………………………………………………………….….. ii 中文摘要 …………………………………………………….….. iii 英文摘要 …………………………………………………….….. v 目錄 ………………………………………………………….….. vii 圖目錄 ……………………………………………………….….. viii 博士論文內容 第一章 緒論 ……………………………………………………. 1 第二章 研究方法與材料 ………………………………………. 26 第三章 結果 ……………………………………………………. 37 第四章 討論 ……………………………………………………. 48 第五章 展望 ……………………………………………………. 68 第六章 論文英文簡述 …………………………………………. 79 第七章 參考文獻 ………………………………………………. 106 第八章 圖表 ……………………………………………………. 131 第九章 附錄 ……………………………………………………. 155 | |
dc.language.iso | zh-TW | |
dc.title | 蜂膠主成份咖啡酸苯乙酯對於人類樹突細胞及T細胞的免疫調節功能及其機轉之探討 | zh_TW |
dc.title | The Regulatory Effect and Mechanism of Caffeic Acid Phenethyl Ester on Human Dendritic Cells and T Cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 王志堯(Jiu-Yao Wang),黃璟隆(Jing-Long Huang),郭敏玲(Ming-Ling Kuo),吳文勉(Wen-Mein Wu) | |
dc.subject.keyword | 咖啡酸苯乙酯,caspase,細胞激素,樹突細胞,NF-κ B,T細胞,訊息傳導, | zh_TW |
dc.subject.keyword | caffeic acid phenethyl ester,caspase,cytokine,dendritic cells,NF-κ B,T cells,signal transduction, | en |
dc.relation.page | 160 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2010-02-11 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 6.97 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。